CompanyPeopleSustainabilityInnovation
CDMOManufacturing CapacityPortfolio and Technologies
Product ListHelp Center
AngolaMozambiqueUSA
Media CenterDownloads
Contact UsFinanced ProjectsGDPRCookies PolicyCorporate Responsability
ABOUT BLUEPHARMA . COMPANY

With eyes set on the Future

bluepharma-sede.jpg
WHO WE ARE
Bluepharma is a privately owned portuguese pharmaceutical group.
Through the entrepreneurship of its promoters, Bluepharma Group currently comprises 20 innovative companies that cover all stages of the pharmaceutical industry value chain.
Know more about us
over
40
worldwide territories
more than
120
worldwide clients
internacional
89%
export rate
OUR HISTORY

In 20 years Bluepharma has grown from a manufacturing plant to a pharmaceutical group of 20 companies.

2021-2025
Bluepharma Park Masterplan, Cernache
High Potent Unit, Eiras
Expansion works, São Martinho
R&D Center 3, São Martinho
Bluepharma celebrates 20 years
Inauguration of the ONConcept® Industrial Unit (Eiras)
Approval of the CiNTech project
Bluepharma Indústria Farmacêutica reinforces capital, through an investment of 30 million euros from C2 Capital
2015-2020
ONConcept® partnership
Patent BlueOS® Technology in US
ColorADD code implementation in Bluepharma´s packs
2011-2015
Logistic platform, Taveiro
GPPC consortium, US
Bluepharma Moçambique
BLPH Angola
Laboratorios Bluepharma, Spain
Bluepharma Brasil
European Business Awards: Best National Exporter.
SME Excellence Award
2006-2010
Launch 1st medicine developed in house
FDA inspection São Martinho do Bispo Plant.
R&D Center 2
Luzitin
Technophage
2001-2005
Bluepharma Indústria Farmacêutica launch upon acquisition Bayer plant, Coimbra
Bluepharma Genéricos
New R&D Center
ISO 9001/2000, ISO 14001/1999, and OHSAS 18000 and EMAS
ACTIVITY
Investment, Innovation, Internationalization, Partnerships, Quality
Bluepharma Group is an entrepreneurial and innovative in the pharmaceutical sector, having already achieved a remarkable international reputation.
In 20 years Bluepharma has grown from a manufacturing plant with 58 people to a pharmaceutical group of 20 companies and more than 750 employees. It has opened offices in 3 countries (Angola, Mozambique and USA) and exported, in 2022, 89% of its production to more than 40 countries.
Know more about our industrial capacity
bluepharma-company-world-en.jpg
BLUEPHARMA GROUP
From R&D to market
With an integrated approach, recognized for the excellence of its production unit, quality and training of its employees, experience and dynamism of its management team.
Holding
bluepharma-sgps-sem-fundo.png
Industry
blph_logo.jpg
Innovation
inobblue.png
luzitin.png
treat-u.png
bsim.png
Healthcare
blgn_logo.jpg
cuidafarma_logo.jpg
blpheua_logo.jpg
aggrega-pharma.jpg
blphmz_logo.jpg
blphao_logo.jpg
Services
blueclinical.png
COIMBRA, PORTUGAL

From Coimbra, best known for its 700 years history university, a mirror of excellence in science.

coimbra-blph.jpg
MISSION, VISION AND VALUES
Bluepharma is a private Portuguese pharmaceutical company, based in Coimbra.
Bluepharma's Mission is the research and development of medicines with high added value and the continuous commitment to the quality and innovation of its manufacturing and commercialization processes. Excellence is the key to Bluepharma's activity.
PARTNERSHIP
Committed to Partnerships (national and international).
VALUES
Bluepharma's vision is guided by the following values: Professionalism, Competence, Honesty, Integrity, Transparency, Commitment.
INVESTMENT
Continuous Investment - in people, facilities and new equipment – to Innovation and Internationalization.
QUALITY
Placing a focus on Quality (the know-how acquired by the experience of more than 50 years of industrial production).

MANAGEMENT BOARD

Bluepharma´s management board members are experienced professionals in the pharmaceutical business.

pb.jpg
PRESIDENT
Paulo Barradas Rebelo
ss.jpg
VICE-PRESIDENT
Sérgio Simões
im.jpg
VICE-PRESIDENT
Maria Isolina Mesquita
qr_q9yvarr-ms.jpeg
VICE-PRESIDENT
Miguel Silvestre
ir.jpg
VICE-PRESIDENT
Ana Isabel Oliveira Rebelo
QUALITY CULTURE

Systematically ensuring the quality of manufactured and distributed medicinal products.

Bluepharma is committed to systematically ensuring the quality of manufactured and distributed products; caring for the environment as well as safeguarding the working conditions of its employees, in compliance with ESG (Environmental, Social and Governance) supported by the Good Manufacturing Practices and by other applicable legislation.

 

Know more also about our Industrial Capacity
LEGISLATION
GOOD MANUFACTURING PRACTICES
ESG
ENVIRONMENTAL, SOCIAL AND GOVERNANCE
SUSTAINABILITY

Also within the scope of its sustainability policy, the internal project Bluelinks was created, which aims to integrate its social, economic and environmental objectives, structuring the various actions and initiatives it promotes.

SUSTAINABILITY
19
internal actions developed for bluepharma's employees (2022)
11
actions developed with bluepharma's employees support (2022)
18
donations (2022)
16
sponsorships (2022)
One of the internal actions of the Blue is Green project is the fight against plastic pollution, with the main purpose of reducing plastic waste generated internally, through the creation of an internal culture of responsible behavior, with a genuine environmental concern.
Know more about Sustainability Policy